Episurf Medical received Israeli Ministry of Health approval to market Episealer® knee products, and entered into a distribution agreement for the region with AMI Technologies.
Episealer devices treat localized cartilage damage in the knee. At the close of 2017, the company announced the 300th surgery with its Episealer personalized implant, representing a doubling of the number of procedures performed as of mid-4Q16.
Episurf Medical received Israeli Ministry of Health approval to market Episealer® knee products, and entered into a distribution agreement for the region with AMI Technologies.
Episealer devices treat localized cartilage damage in the knee. At the close of 2017, the company announced the 300th surgery with its...
Episurf Medical received Israeli Ministry of Health approval to market Episealer® knee products, and entered into a distribution agreement for the region with AMI Technologies.
Episealer devices treat localized cartilage damage in the knee. At the close of 2017, the company announced the 300th surgery with its Episealer personalized implant, representing a doubling of the number of procedures performed as of mid-4Q16.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
